Outlook on the Macrolide Antibiotics Global Market to 2027 - Focus on Azithromycin, Clarithromycin, Erythromycin, Fidaxomicin and Telithromycin - ResearchAndMarkets.com
The global macrolide antibiotics market is anticipated to grow at a considerable CAGR during the forecast period.
The "Global Macrolide Antibiotics Market 2021-2027" report has been added to ResearchAndMarkets.com's offering.
The global macrolide antibiotics market is anticipated to grow at a considerable CAGR during the forecast period. The market is likely to be driven by pharmaceutical firms' increasing efforts to discover innovative treatments to treat infectious illnesses.
According to the Pew Charitable Trust, in December 2019, about 41 promising compounds for the treatment of severe bacterial infections were being studied. Furthermore, favorable government legislation like the GAIN Act and the REVAMP Act is expected to speed up the clearance process throughout the world. Over the forecast period, the introduction of novel antibiotic drugs is likely to drive market growth.
The global macrolide antibiotics market is segmented based on drugs, route of administration, indication and end-user. Based on drugs, the market is sub-segmented into azithromycin, clarithromycin, erythromycin, fidaxomicin and telithromycin. On the basis of route of administration, the market is sub-segmented into oral and parenteral. On the basis of indication, the market is sub-segmented into mycoplasma pneumonia, legionella sp., bordetella pertussis, symptomatic cat-scratch disease, bacillary angiomatosis, peliosishepatis, cerebral toxoplasmosis and uncomplicated skin infections. On the basis of end-user, the market is sub-segmented into hospital, dermatology clinic, clinic, ambulatory centre and research laboratories.
Geographically, the global macrolide antibiotics market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. Some of the companies operating in the global macrolide antibiotics market include Merck Sharp & Dohme Corp., Pfizer Inc., Macrolide Pharmaceuticals, and Teva Pharmaceutical Industries Ltd. among others.
Market Segmentation
- Global Macrolide Antibiotics Market Research and Analysis by Drugs
- Global Macrolide Antibiotics Market Research and Analysis by Route of Administration
- Global Macrolide Antibiotics Market Research and Analysis by Indication
- Global Macrolide Antibiotics Market Research and Analysis by End-User
The Report Covers
- Comprehensive research methodology of the global macrolide antibiotics market.
- This report also includes a detailed and extensive market overview with key analyst insights.
- An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
- Analysis of regional regulations and other government policies impacting the global Macrolide antibiotics market.
- Insights about market determinants that are stimulating the global macrolide antibiotics market.
- Detailed and extensive market segments with the regional distribution of forecasted revenues.
- Extensive profiles and recent developments of market players.
Key Topics Covered:
1. Report Summary
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Market Determinants
3.1. Motivators
3.2. Restraints
3.3. Opportunities
4. Market Segmentation
4.1. Global Marcolide Antibiotics Market By Drugs
4.1.1. Azithromycin
4.1.2. Clarithromycin
4.1.3. Erythromycin
4.1.4. Fidaxomicin
4.1.5. Telithromycin
4.2. Global Marcolide Antibiotics Market By Route of Administration
4.2.1. Oral
4.2.2. Parenteral
4.3. Global Marcolide Antibiotics Market by Indication
4.3.1. Mycoplasma Pneumonia
4.3.2. Legionella sp.
4.3.3. Bordetella Pertussis
4.3.4. Symptomatic Cat-Scratch Disease
4.3.5. Bacillary angiomatosis
4.3.6. Peliosishepatis
4.3.7. Cerebral Toxoplasmosis
4.3.8. Uncomplicated Skin Infections Others
4.4. Global Marcolide Antibiotics Market by End-User
4.4.1. Hospital
4.4.2. Dermatology Clinic
4.4.3. Ambulatory Center
4.4.4. Research Laboratories
5. Regional Analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Fresenius Kabi USA
6.2. Gland Pharma Ltd.
6.3. Macrolide Pharmaceuticals
6.4. Merck Sharp & Dohme Corp.
6.5. Mylan N.V.
6.6. Neo Quimica
6.7. Pfizer Inc.
6.8. Sandoz International GmbH
6.9. Teva Pharmaceutical Industries Ltd.
6.10. WOCKHARDT
For more information about this report visit https://www.researchandmarkets.com/r/1gyrer
View source version on businesswire.com: https://www.businesswire.com/news/home/20220512005570/en/